Background As the COVID-19 pandemic spread across the United States, America's
pharmacists and their teammates expanded their clinical services to help their communities …

While some studies have previously estimated lives saved by COVID-19 vaccination, we
estimate how many deaths could have been averted by vaccination in the US but were not …

Background Over 1 million people in the United States have died of COVID-19. In response
to this public health crisis, the US Department of Health and Human Services launched the …

We examined COVID-19 concerns, vaccine acceptance, and trusted sources of information
among patients in a safety-net health system in Louisiana. The participants were surveyed …

Background New coronavirus disease 2019 (COVID-19) medications force decision-makers
to weigh limited evidence of efficacy and cost in determining which patient populations to …

Background While vaccines have established utility against COVID-19, phase 3 efficacy
studies have generally not comprehensively evaluated protection provided by previous …

COVID-19 vaccine hesitancy has been a major limiting factor to the widespread uptake of
COVID-19 vaccination in the United States. A range of interventions, including mass media …

In December 2020, 11 months after identifying the first laboratory-confirmed case of COVID-
19 in the United States, the US Food and Drug Administration authorized emergency use of …

BACKGROUND Throughout the COVID-19 pandemic, deaths from COVID-19 have been
higher among adults 65 and older than all other age groups, and early in the pandemic …

Introduction Monovalent COVID-19 boosters lower the risk of COVID-19 disease, infection,
hospitalization, and death. This study examined associations between exposure to a booster …